Published in Cancer Weekly, May 19th, 1997
Nonetheless, with the exception of the PSA marker, current in vitro cancer diagnostic products cannot identify cancer early enough. There remains considerable need for improved tests to detect cancer cells, and for tests specific enough to detect changes in cancer cells that may determine treatment protocols and prognosis.
The latest advances toward developing such diagnostic technologies is the subject of the Decision Resources report, "New Strategies in In Vitro Cancer Diagnostics." Immunodiagnostics and the detection of tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.